Citius Oncology, Inc. CTOR Effective Income Tax Rate Reconciliation Permanent Differences

Effective Income Tax Rate Reconciliation Permanent Differences at other companies

RE/MAX HoldingsRMAX

23.3%+20.7pp

ZumiezZUMZ

6%+5.7pp

Community Health SystemsCYH

$750K-57.1%

Community Health SystemsCYH

0.4%+0.2pp

HitachiHIT

-0.2%-0.7pp

Spectral AI, Inc.MDAI

-7.3%-0.7pp

Revenue$1.7M—

Gross profit$1.3M—

Operating income-$28.6M-283%

Net income-$26.6M-244%

EPS (diluted)-$0.27-145%

Cash & equivalents$2.6M+2,350,466%

Total equity$35.3M-1.0%

Total assets$100.7M+10.1%

Operating cash flow-$3.8M-179%

Market cap$60.45M-74.7%

Return on equity-119.9%+46.7pp

Current ratio0.5×+0.1×

Reported directly by Citius Oncology, Inc. in its filing.

Tagged under the XBRL concept ctor:EffectiveIncomeTaxRateReconciliationPermanentDifferences.

The official record: Citius Oncology, Inc.’s 10-K, filed December 23, 2025, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Citius Oncology, Inc.'s effective income tax rate reconciliation permanent differences?: Citius Oncology, Inc. (CTOR) reported effective income tax rate reconciliation permanent differences of 6.3% in Q3 2025.
What does effective income tax rate reconciliation permanent differences mean?: Represents the impact of permanent differences between financial reporting income and taxable income on the effective tax rate. These items are never deductible or taxable for tax purposes, creating a lasting divergence from the statutory tax rate. Monitoring this helps investors understand the structural tax efficiency of the company's operations.